Too Much Fluid, Too Little Space
Hydrocephalus — the abnormal accumulation of cerebrospinal fluid (CSF) within the brain's ventricles — exerts progressive pressure on delicate brain tissue. In dogs, the condition divides neatly into a congenital form, present from birth and strongly linked to certain small breeds, and an acquired form that develops secondary to another disease process. A 2019 survey of veterinary neurology referrals found that toy and miniature breeds accounted for the overwhelming majority of congenital hydrocephalus cases, often presenting in the first months of life. Recognising the signs early can significantly change outcomes.
How Hydrocephalus Develops
CSF is produced continuously by the choroid plexus within the brain's ventricles, circulates through the ventricular system and around the brain and spinal cord, and is reabsorbed into the venous circulation. When any part of this process is disrupted — whether by a developmental obstruction, inflammation, haemorrhage, or tumour — fluid accumulates and ventricular pressure rises. In congenital cases, the aqueduct of Sylvius (the channel connecting the third and fourth ventricles) is commonly malformed or stenotic. In acquired cases, conditions such as inflammatory brain disease, intracranial tumours, or the aftermath of meningitis can obstruct CSF flow. The end result in both scenarios is ventriculomegaly: abnormal enlargement of the ventricular spaces at the expense of surrounding brain tissue.
Breeds Most Affected
Congenital hydrocephalus shows a striking predilection for brachycephalic and toy breeds:
- Chihuahuas: By far the most commonly affected breed, with some studies suggesting that a degree of ventriculomegaly is present in the majority of the breed population, though not all are clinically affected.
- Yorkshire Terriers: Frequently diagnosed, often alongside other structural brain anomalies.
- Maltese: A recognised breed predisposition.
- Pugs and French Bulldogs: Their compressed skull anatomy predisposes them to abnormal CSF dynamics.
- Pomeranians, Toy Poodles, and Boston Terriers: All appear in the literature at elevated frequency.
The presence of a persistent open fontanelle (a soft spot on the skull) and a dome-shaped skull are physical indicators that should prompt evaluation in a young small-breed dog, even before neurological signs appear.
Clinical Signs
Signs vary considerably with the degree of ventricular enlargement and rate of progression. Mild ventriculomegaly may cause no observable signs at all. When symptoms are present, they typically include:
- Altered mentation: dullness, confusion, appearing to stare at walls.
- Behavioural changes: aggression where none existed, loss of learnt behaviours, difficulty with house training.
- Seizures: often the presenting complaint in younger dogs.
- Visual deficits or blindness: due to pressure on the visual cortex or optic pathways.
- Abnormal gait, circling, or head pressing.
- Failure to thrive or delayed development in puppies.
In very young puppies, a disproportionately large, domed skull is visible on inspection and palpation alone.
Diagnosis and Imaging
MRI provides the most comprehensive assessment, allowing visualisation of ventricular size, any obstruction site, and the condition of surrounding brain tissue. Ultrasound through an open fontanelle is a rapid, non-invasive screening tool that can confirm ventricular enlargement in puppies without requiring general anaesthesia. CT scanning is faster than MRI and useful for surgical planning. CSF analysis helps differentiate inflammatory from purely mechanical causes. Concurrent conditions — particularly brain inflammation or intracranial masses — must be ruled out before classifying a case as purely congenital.
Medical Management
Medical management aims to reduce CSF production and alleviate pressure. Corticosteroids, particularly prednisolone, reduce CSF production and can produce meaningful clinical improvement in mild to moderate cases. Omeprazole (a proton pump inhibitor) has also been shown to reduce CSF production and is used as a longer-term adjunct, often in combination with steroids. Diuretics such as furosemide or acetazolamide have been employed but are generally considered less effective and carry more side-effect risk. Medical management rarely provides permanent resolution but can stabilise mild cases or serve as a bridge to surgery.
When Surgery Helps
Ventriculoperitoneal (VP) shunting is the surgical treatment of choice and involves placing a catheter within the lateral ventricle connected via a subcutaneous pressure-sensitive valve to the peritoneal cavity, where excess CSF drains safely. The procedure requires specialist neurosurgical expertise and carries risks including shunt infection, blockage, and over-drainage. Outcomes, however, can be remarkable. Dogs with moderate to severe hydrocephalus that is not controlled medically, or those who have deteriorated significantly, are the clearest surgical candidates. Younger patients with shorter disease duration tend to have better post-operative outcomes, as the brain retains greater plasticity and some functions can be recovered. Older dogs with long-standing pressure changes and brain tissue loss have a more guarded prognosis even after successful shunt placement.
Post-Operative Considerations
Shunt complications occur in a meaningful proportion of cases and require lifelong monitoring. Owners should be aware of signs of shunt failure — acute neurological deterioration, return of seizures, altered consciousness — and have a clear emergency plan agreed with their neurologist. Regular re-checks, typically every three to six months initially, are essential.
- If your small-breed puppy has a soft skull spot or domed head, request early neurological assessment.
- Begin medical management as soon as clinical signs appear — do not wait for deterioration.
- Seek referral to a veterinary neurosurgical centre for VP shunt assessment if medical management is inadequate.
- Understand that shunts require long-term follow-up and have a failure risk that must be managed proactively.
- Always confirm diagnosis with MRI or ultrasound before committing to a treatment pathway.